| Organism name | Erycibe expansa |
|---|---|
| Genus | Erycibe |
| Family | Convolvulaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Erycibe |
|---|---|
| Linked NCBI taxonomy ID | 197385 |
| Linked level | genus |
| Family in NCBI taxonomy | Convolvulaceae |
|---|---|
| ID | 4118 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00000960
|
Eriodictyol
|
CHEMBL8996
CHEMBL307893 CHEMBL1975989 |
C007619
|
32 / 29 / 55 | 5 / 0 | No. 25 | No. 14 |
|
|
C00030207
|
Erycibenin D
/ (-)-Erycibenin D |
CHEMBL241571
|
No. 42 | No. 14 |
|
|||
|
C00003672
|
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
|
||
|
C00000674
|
Luteolin
|
CHEMBL151
|
D047311
|
99 / 91 / 95 | 76 / 6 | No. 71 | No. 15 |
|
|
C00030209
|
Erycibenin F
/ (-)-Erycibenin F |
CHEMBL391981
|
No. 73 | No. 15 |
|
|||
|
C00029556
|
5,7-Dimethoxy-4'-hydroxyflavan
/ (+/-)-5,7-Dimethoxy-4'-hydroxyflavan |
CHEMBL397828
|
No. 73 | No. 15 |
|
|||
|
C00030208
|
Erycibenin E
/ (-)-Erycibenin E |
CHEMBL241569
|
No. 73 | No. 15 |
|
|||
|
C00001232
|
Oleic acid
/ (Z)-9-Octadecenoic acid |
CHEMBL8659
CHEMBL460657 |
D019301
|
30 / 19 / 20 | 26 / 9 | No. 184 | No. 68 |
|
|
C00030205
|
Erycibenin B
/ (+)-Erycibenin B |
CHEMBL427693
|
No. 240 |
|
||||
|
C00030204
|
Erycibenin A
/ (+)-Erycibenin A |
CHEMBL241817
|
No. 240 |
|
||||
|
C00002537
|
Rotenolone
/ 12a-Hydroxyrotenone |
CHEMBL240545
|
No. 281 | No. 15 |
|
|||
|
C00002568
|
Rotenone
/ Tubotoxin / Nicouline |
CHEMBL429023
CHEMBL267461 CHEMBL418710 CHEMBL1518927 |
D012402
|
129 / 92 / 86 | 177 / 42 | No. 281 | No. 15 |
|
|
C00001224
|
Linoleic acid
/ (Z,Z)-9,12-Octadecadienoic acid |
CHEMBL267476
|
29 / 31 / 28 | No. 367 | No. 68 |
|
||
|
C00030206
|
Erycibenin C
/ (-)-Erycibenin C |
CHEMBL240929
|
No. 396 | No. 15 |
|
|||
|
C00019308
|
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
|
|
|
C00002578
|
Tephrosin
|
CHEMBL241806
|
C480848
|
6 / 0 | No. 589 | No. 15 |
|
|
|
C00002522
|
Deguelin
/ (-)-cis-Deguelin |
CHEMBL393417
CHEMBL1592086 |
C107676
|
12 / 20 / 45 | 86 / 10 | No. 589 | No. 15 |
|
|
C00030643
|
Lasiodiplodin
|
CHEMBL393258
CHEMBL1669748 |
No. 790 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000674 C00000960 C00001224 C00002522 C00002568 C00003672 | 0 / 1 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000674 C00000960 C00001232 C00002522 C00002568 | 4 / 3 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000674 C00001224 C00002522 C00002568 C00003672 | 3 / 2 |
| P06746 | DNA polymerase beta | Enzyme | C00000674 C00000960 C00002568 C00003672 C00019308 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000674 C00000960 C00002522 C00002568 C00003672 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000674 C00001224 C00001232 C00002522 C00002568 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00000674 C00000960 C00001224 C00001232 C00002568 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000674 C00002522 C00002568 C00003672 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000674 C00000960 C00001224 C00002568 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000674 C00000960 C00001232 C00002522 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000674 C00000960 C00001224 C00001232 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000674 C00000960 C00002522 C00002568 | 7 / 37 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000674 C00002522 C00002568 C00003672 | 0 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000674 C00002522 C00002568 C00003672 | 1 / 1 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000674 C00000960 C00001224 C00001232 | 3 / 3 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000674 C00001224 C00002568 C00003672 | 1 / 1 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000674 C00000960 C00001224 C00002568 | 2 / 2 |
| P03372 | Estrogen receptor | NR3A1 | C00000674 C00001224 C00002568 C00003672 | 1 / 1 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000674 C00001232 C00002568 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000674 C00000960 C00002568 | 1 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000674 C00000960 C00001224 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000674 C00000960 C00002568 | 0 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001224 C00001232 C00002568 | 5 / 3 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00000674 C00000960 C00001232 | 0 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00000674 C00003672 C00019308 | 0 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00000674 C00001224 C00002568 | 3 / 4 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000674 C00002522 C00002568 | 4 / 1 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000674 C00001224 C00002568 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00000674 C00001232 C00002568 | 1 / 2 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000674 C00000960 C00002568 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000674 C00000960 C00002568 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000674 C00001224 C00002568 | 11 / 10 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00001224 C00002568 | 0 / 0 |
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00000674 C00000960 | 2 / 1 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000674 C00000960 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000674 C00002568 | 0 / 0 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00019308 | 0 / 0 |
| P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00001224 C00001232 | 0 / 0 |
| P35610 | Sterol O-acyltransferase 1 | Enzyme | C00001224 C00001232 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00000674 C00002568 | 3 / 1 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00001224 C00002568 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00019308 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000674 C00002568 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000674 C00002568 | 1 / 1 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001224 C00001232 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000674 C00002568 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00000674 C00002568 | 1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002568 C00003672 | 2 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000674 C00002568 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001232 C00002568 | 2 / 2 |
| P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00001224 C00001232 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000960 C00002568 | 0 / 0 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00000674 C00000960 | 0 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00001224 C00001232 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00000674 C00003672 | 1 / 0 |
| P13726 | Tissue factor | Membrane receptor | C00001224 C00001232 | 0 / 0 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00000674 C00000960 | 4 / 4 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000674 C00000960 | 1 / 1 |
| P14679 | Tyrosinase | Oxidoreductase | C00000674 C00003672 | 4 / 2 |
| P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00000674 C00002568 | 0 / 0 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001224 C00001232 | 2 / 2 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000674 C00002568 | 0 / 1 |
| P00734 | Prothrombin | S1A | C00003672 C00019308 | 4 / 2 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00000674 C00000960 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000674 C00002568 | 2 / 2 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001232 C00002568 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000674 C00001232 | 1 / 2 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00000674 C00000960 | 1 / 1 |
| Q9UGP5 | DNA polymerase lambda | Enzyme | C00001224 C00001232 | 0 / 0 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00000674 C00001232 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000674 C00002568 | 0 / 1 |
| P17252 | Protein kinase C alpha type | Alpha | C00001232 C00002568 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001232 C00002568 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001224 C00001232 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00000674 C00000960 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000674 C00002568 | 0 / 0 |
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00000674 C00000960 | 1 / 1 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000674 C00000960 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00002568 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002568 | 1 / 1 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002568 | 0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002568 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002568 | 1 / 0 |
| P39900 | Macrophage metalloelastase | M10A | C00000674 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002568 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002568 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002568 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00002568 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002568 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000674 | 2 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002568 | 0 / 0 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002568 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00000674 | 4 / 2 |
| P23528 | Cofilin-1 | Unclassified protein | C00002568 | 0 / 0 |
| P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000674 | 0 / 1 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002568 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002568 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002568 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00002568 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00002568 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002568 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002568 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002568 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002568 | 1 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002568 | 2 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002568 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00002568 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002568 | 1 / 0 |
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00001232 | 0 / 0 |
| P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00000674 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000674 | 0 / 0 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002568 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002568 | 1 / 8 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00000674 | 1 / 0 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000960 | 0 / 0 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000960 | 3 / 1 |
| Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00000674 | 0 / 0 |
| P51570 | Galactokinase | Enzyme | C00000674 | 1 / 1 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00002522 | 0 / 0 |
| Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00000674 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00002568 | 0 / 0 |
| Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00000674 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000674 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002568 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002568 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002568 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002568 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002568 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002568 | 2 / 0 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00000674 | 0 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002568 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002568 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002568 | 0 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00002568 | 0 / 0 |
| P06276 | Cholinesterase | Hydrolase | C00000674 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002568 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002568 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002568 | 0 / 0 |
| P06280 | Alpha-galactosidase A | Enzyme | C00000674 | 1 / 1 |
| P04745 | Alpha-amylase 1 | Enzyme | C00000674 | 0 / 0 |
| P45452 | Collagenase 3 | M10A | C00000674 | 1 / 1 |
| P49327 | Fatty acid synthase | Transferase | C00000674 | 0 / 0 |
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00000674 | 2 / 0 |
| P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00001224 | 0 / 0 |
| P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00001224 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002568 | 1 / 0 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00000674 | 0 / 0 |
| P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000960 | 0 / 1 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002568 | 2 / 1 |
| P04062 | Glucosylceramidase | Enzyme | C00000674 | 6 / 4 |
| P03905 | NADH-ubiquinone oxidoreductase chain 4 | Oxidoreductase | C00002568 | 3 / 1 |
| P08253 | 72 kDa type IV collagenase | M10A | C00000674 | 1 / 3 |
| Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00001232 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002568 | 0 / 0 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000674 | 2 / 0 |
| P07148 | Fatty acid-binding protein, liver | Unclassified protein | C00001232 | 0 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002568 | 1 / 1 |
| Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00000674 | 1 / 0 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002568 | 1 / 1 |
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00002568 | 5 / 2 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00001232 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002568 | 0 / 0 |
| Q9H2K2 | Tankyrase-2 | Enzyme | C00000674 | 0 / 0 |
| O14763 | Tumor necrosis factor receptor superfamily member 10B | Unclassified protein | C00000674 | 1 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002568 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002568 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002568 | 1 / 0 |
| P08246 | Neutrophil elastase | S1A | C00002568 | 2 / 1 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002568 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002568 | 0 / 0 |
| Q9Y3R4 | Sialidase-2 | Enzyme | C00000674 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002568 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00002568 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002568 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002568 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00000674 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002568 | 0 / 0 |
| O14842 | Free fatty acid receptor 1 | Free fatty acid receptor | C00001224 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002568 | 0 / 0 |
| Q15046 | Lysine--tRNA ligase | Enzyme | C00000674 | 2 / 1 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00002568 | 1 / 0 |
| P14618 | Pyruvate kinase PKM | Enzyme | C00000960 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002568 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002568 | 1 / 0 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002568 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00002568 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000674 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002568 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002568 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00002568 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002568 | 1 / 1 |
| P05412 | Transcription factor AP-1 | Transcription Factor | C00002568 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002568 | 0 / 1 |
| Q04760 | Lactoylglutathione lyase | Enzyme | C00000674 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002568 | 0 / 0 |
| P08254 | Stromelysin-1 | M10A | C00000674 | 1 / 0 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
| Q9NPH5 | NADPH oxidase 4 | Enzyme | C00000674 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00002568 | 1 / 2 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000674 | 1 / 1 |
| P40225 | Thrombopoietin | Unclassified protein | C00002568 | 1 / 1 |
| Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001232 | 1 / 4 |
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002568 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00000674 | 2 / 5 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00000674 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00000674 | 1 / 4 |
| O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00000674 | 0 / 0 |
| P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00000674 | 0 / 0 |
| Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00000674 | 0 / 0 |
| P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00000674 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002568 | 0 / 0 |
| O95271 | Tankyrase-1 | Enzyme | C00000674 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000674
C00001232
C00002522
C00002568
C00002578 |
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00000674
C00002522
C00002578
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001232
C00002522
C00002568
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000674
C00002522
C00002568
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001232
C00002522
C00002568
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000674
C00002522
C00002578
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000674
C00002522
C00002568
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001232
C00002522
C00002568
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00000674
C00002522
C00002568
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000674
C00002522
C00002568
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000674
C00002522
C00002568
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00000674
C00001232
C00002568
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00000674
C00002522
C00002568
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000674
C00002522
C00002568
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000674
C00002568
|
| 672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00002522
C00002568
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000674
C00002568
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002522
C00002568
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000674
C00002568
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000674
C00002568
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000674
C00002568
|
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00000674
C00002522
|
| 545 | ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1 | ataxia telangiectasia and Rad3 related (EC:2.7.11.1) |
C00002522
C00002568
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000674
C00002568
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000674
C00002568
|
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002568
C00002578
|
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00000674
C00002578
|
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00000674
C00002522
|
| 472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002522
C00002568
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002522
C00002568
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00000674
C00002522
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000674
C00002568
|
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002522
C00002568
|
| 6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00002522
C00002568
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000674
C00002522
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00001232
C00002522
|
| 6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00001232
C00002568
|
| 5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2) |
C00002522
C00002568
|
| 29110 | TBK1, NAK, T2K | TANK-binding kinase 1 (EC:2.7.11.1) |
C00000674
C00000960
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002522
C00002568
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000960
C00002568
|
| 3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00002522
C00002568
|
| 4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00002522
C00002568
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000960
C00002568
|
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000674
C00002522
|
| 9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00000674
C00001232
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00000674
C00000960
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000674
|
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002522
|
| 5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00002522
|
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002522
|
| 4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002522
|
| 4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00002522
|
| 3791 | KDR, CD309, FLK1, VEGFR, VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) |
C00002522
|
| 2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00002522
|
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002522
|
| 8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00002522
|
| 3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002522
|
| 3549 | IHH, BDA1, HHG2 | indian hedgehog |
C00002522
|
| 4928 | NUP98, ADIR2, NUP196, NUP96 | nucleoporin 98kDa |
C00002522
|
| 3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00002522
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002522
|
| 8325 | FZD8, FZ-8, hFZ8 | frizzled family receptor 8 |
C00002522
|
| 5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) |
C00002522
|
| 5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002522
|
| 8322 | FZD4, CD344, EVR1, FEVR, FZD4S, Fz-4, Fz4, FzE4, GPCR, hFz4 | frizzled family receptor 4 |
C00002522
|
| 11211 | FZD10, CD350, FZ-10, Fz10, FzE7, hFz10 | frizzled family receptor 10 |
C00002522
|
| 2487 | FRZB, FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, OS1, SFRP3, SRFP3, hFIZ | frizzled-related protein |
C00002522
|
| 6194 | RPS6, S6 | ribosomal protein S6 |
C00002522
|
| 6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00002522
|
| 6423 | SFRP2, FRP-2, SARP1, SDF-5 | secreted frizzled-related protein 2 |
C00002522
|
| 2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00002522
|
| 8403 | SOX14, SOX28 | SRY (sex determining region Y)-box 14 |
C00002522
|
| 11063 | SOX30 | SRY (sex determining region Y)-box 30 |
C00002522
|
| 6660 | SOX5, L-SOX5 | SRY (sex determining region Y)-box 5 |
C00002522
|
| 6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) |
C00002522
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00002522
|
| 6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00002522
|
| 412 | STS, ARSC, ARSC1, ASC, ES, SSDD, XLI | steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) |
C00002522
|
| 6925 | TCF4, E2-2, ITF-2, ITF2, PTHS, SEF-2, SEF2, SEF2-1, SEF2-1A, SEF2-1B, TCF-4, bHLHb19 | transcription factor 4 |
C00002522
|
| 112399 | EGLN3, HIFP4H3, HIFPH3, PHD3 | egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29) |
C00002522
|
| 27121 | DKK4, DKK-4 | dickkopf WNT signaling pathway inhibitor 4 |
C00002522
|
| 27123 | DKK2, DKK-2 | dickkopf WNT signaling pathway inhibitor 2 |
C00002522
|
| 11197 | WIF1, WIF-1 | WNT inhibitory factor 1 |
C00002522
|
| 80326 | WNT10A, OODD, SSPS, STHAG4 | wingless-type MMTV integration site family, member 10A |
C00002522
|
| 7481 | WNT11, HWNT11 | wingless-type MMTV integration site family, member 11 |
C00002522
|
| 7222233 |
C00002522
|
||
| 7472 | WNT2, INT1L1, IRP | wingless-type MMTV integration site family member 2 |
C00002522
|
| 7482 | WNT2B, WNT13, XWNT2 | wingless-type MMTV integration site family, member 2B |
C00002522
|
| 89780 | WNT3A | wingless-type MMTV integration site family, member 3A |
C00002522
|
| 7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002522
|
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00002522
|
| 7122 | CLDN5, AWAL, BEC1, CPETRL1, TMVCF | claudin 5 |
C00002522
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002578
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002568
|
| 28976 | ACAD9, NPD002 | acyl-CoA dehydrogenase family, member 9 |
C00002568
|
| 48 | ACO1, ACONS, IREB1, IREBP, IREBP1, IRP1 | aconitase 1, soluble (EC:4.2.1.3) |
C00002568
|
| 50 | ACO2, ACONM, ICRD | aconitase 2, mitochondrial (EC:4.2.1.3) |
C00002568
|
| 54 | ACP5, SPENCDI, TRAP | acid phosphatase 5, tartrate resistant (EC:3.1.3.2) |
C00002568
|
| 59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00002568
|
| 183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00002568
|
| 9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00002568
|
| 290 | ANPEP, APN, CD13, GP150, LAP1, P150, PEPN | alanyl (membrane) aminopeptidase (EC:3.4.11.2) |
C00002568
|
| 317 | APAF1, APAF-1, CED4 | apoptotic peptidase activating factor 1 |
C00002568
|
| 402 | ARL2, ARFL2 | ADP-ribosylation factor-like 2 |
C00002568
|
| 468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00002568
|
| 9474 | ATG5, APG5, APG5-LIKE, APG5L, ASP, hAPG5 | autophagy related 5 |
C00002568
|
| 514 | ATP5E, ATPE, MC5DN3 | ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (EC:3.6.3.14) |
C00002568
|
| 518 | ATP5G3, P3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
C00002568
|
| 521 | ATP5I, ATP5K | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E (EC:3.6.1.14) |
C00002568
|
| 522 | ATP5J, ATP5, ATP5A, ATPM, CF6, F6 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 (EC:3.6.1.14) |
C00002568
|
| 10632 | ATP5L, ATP5JG | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G (EC:3.6.1.14) |
C00002568
|
| 539 | ATP5O, ATPO, OSCP | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (EC:3.6.3.14) |
C00002568
|
| 4287 | ATXN3, AT3, ATX3, JOS, MJD, MJD1, SCA3 | ataxin 3 (EC:3.4.19.12) |
C00002568
|
| 23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002568
|
| 572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002568
|
| 580 | BARD1 | BRCA1 associated RING domain 1 |
C00002568
|
| 9075 | CLDN2 | claudin 2 |
C00002522
|
| 8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00002568
|
| 675 | BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2 | breast cancer 2, early onset |
C00002568
|
| 701 | BUB1B, BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1 | BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) |
C00002568
|
| 8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00002522
|
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002522
|
| 902 | CCNH, CAK, p34, p37 | cyclin H |
C00002568
|
| 929 | CD14 | CD14 molecule |
C00002568
|
| 948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00002568
|
| 952 | CD38, T10 | CD38 molecule (EC:3.2.2.5) |
C00002568
|
| 999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002568
|
| 1111 | CHEK1, CHK1 | checkpoint kinase 1 (EC:2.7.11.1) |
C00002568
|
| 29883 | CNOT7, CAF1, Caf1a, hCAF-1 | CCR4-NOT transcription complex, subunit 7 (EC:3.1.13.4) |
C00002568
|
| 1270 | CNTF, HCNTF | ciliary neurotrophic factor |
C00002568
|
| 1293 | COL6A3 | collagen, type VI, alpha 3 |
C00002568
|
| 1327 | COX4I1, COX4, COX4-1, COXIV | cytochrome c oxidase subunit IV isoform 1 (EC:1.9.3.1) |
C00002568
|
| 9377 | COX5A, COX, COX-VA, VA | cytochrome c oxidase subunit Va (EC:1.9.3.1) |
C00002568
|
| 1329 | COX5B, COXVB | cytochrome c oxidase subunit Vb (EC:1.9.3.1) |
C00002568
|
| 1347 | COX7A2, COX7AL, COX7AL1, COXVIIAL, COXVIIa-L, VIIAL | cytochrome c oxidase subunit VIIa polypeptide 2 (liver) (EC:1.9.3.1) |
C00002568
|
| 1349 | COX7B, APLCC | cytochrome c oxidase subunit VIIb (EC:1.9.3.1) |
C00002568
|
| 1356 | CP, CP-2 | ceruloplasmin (ferroxidase) (EC:1.16.3.1) |
C00002568
|
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002568
|
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002568
|
| 1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
C00002568
|
| 10072 | DPP3, DPPIII | dipeptidyl-peptidase 3 (EC:3.4.14.4) |
C00002568
|
| 9451 | EIF2AK3, PEK, PERK, WRS | eukaryotic translation initiation factor 2-alpha kinase 3 (EC:2.7.11.1) |
C00002568
|
| 1965 | EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
C00002568
|
| 9156 | EXO1, HEX1, hExoI | exonuclease 1 |
C00002568
|
| 2175 | FANCA, FA, FA-H, FA1, FAA, FACA, FAH, FANCH | Fanconi anemia, complementation group A |
C00002568
|
| 2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00002568
|
| 2177 | FANCD2, FA-D2, FA4, FACD, FAD, FAD2, FANCD | Fanconi anemia, complementation group D2 |
C00002568
|
| 2178 | FANCE, FACE, FAE | Fanconi anemia, complementation group E |
C00002568
|
| 2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00002568
|
| 2189 | FANCG, FAG, XRCC9 | Fanconi anemia, complementation group G |
C00002568
|
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002568
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002568
|
| 1007 | CDH9 | cadherin 9, type 2 (T1-cadherin) |
C00002522
|
| 2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00002568
|
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00002568
|
| 10456 | HAX1, HCLSBP1, HS1BP1, SCN3 | HCLS1 associated protein X-1 |
C00002568
|
| 3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00002568
|
| 27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00002568
|
| 3364 | HUS1, hHUS1 | HUS1 checkpoint homolog (S. pombe) |
C00002568
|
| 3419 | IDH3A | isocitrate dehydrogenase 3 (NAD+) alpha (EC:1.1.1.41) |
C00002568
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00002568
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002568
|
| 3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00002568
|
| 3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00002568
|
| 1005 | CDH7, CDH7L1 | cadherin 7, type 2 |
C00002522
|
| 3952 | LEP, LEPD, OB, OBS | leptin |
C00002568
|
| 120892 | LRRK2, AURA17, DARDARIN, PARK8, RIPK7, ROCO2 | leucine-rich repeat kinase 2 (EC:2.7.11.1) |
C00002568
|
| 1001 | CDH3, CDHP, HJMD, PCAD | cadherin 3, type 1, P-cadherin (placental) |
C00002522
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002568
|
| 768 | CA9, CAIX, MN | carbonic anhydrase IX (EC:4.2.1.1) |
C00002522
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00002522
|
| 4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00002568
|
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002568
|
| 4361 | MRE11A, ATLD, HNGS1, MRE11, MRE11B | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
C00002568
|
| 64965 | MRPS9, MRP-S9, RPMS9, S9mt | mitochondrial ribosomal protein S9 |
C00002568
|
| 4481 | MSR1, CD204, SCARA1, SR-A, SRA, phSR1, phSR2 | macrophage scavenger receptor 1 |
C00002568
|
| 4490 | MT1B, MT1, MT1Q, MTP | metallothionein 1B |
C00002568
|
| 4502 | MT2A, MT2 | metallothionein 2A |
C00002568
|
| 80198 | MUS81, SLX3 | MUS81 structure-specific endonuclease subunit (EC:3.1.22.-) |
C00002568
|
| 10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00002568
|
| 4541 | ND6, MTND6, MT-ND6 | NADH dehydrogenase, subunit 6 (complex I) |
C00002568
|
| 4705 | NDUFA10, CI-42KD, CI-42k | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4696 | NDUFA3, B9, CI-B9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa |
C00002568
|
| 4697 | NDUFA4, CI-9k, CI-MLRQ, MLRQ | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4700 | NDUFA6, B14, CI-B14, LYRM6, NADHB14 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
C00002568
|
| 4704 | NDUFA9, CC6, CI-39k, CI39k, NDUFS2L, SDR22E1 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa |
C00002568
|
| 4707 | NDUFB1, CI-MNLL, CI-SGDH, MNLL | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
C00002568
|
| 4708 | NDUFB2, AGGG, CI-AGGG | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4709 | NDUFB3, B12, CI-B12 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa |
C00002568
|
| 4710 | NDUFB4, B15, CI-B15 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4711 | NDUFB5, CISGDH, SGDH | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4712 | NDUFB6, B17, CI | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4713 | NDUFB7, B18, CI-B18 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4714 | NDUFB8, ASHI, CI-ASHI | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa |
C00002568
|
| 4724 | NDUFS4, AQDQ, CI-18 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
C00002568
|
| 4726 | NDUFS6, CI-13kA, CI-13kD-A, CI13KDA | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 4728 | NDUFS8, CI-23k, CI23KD, TYKY | NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00002568
|
| 10725 | NFAT5, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP | nuclear factor of activated T-cells 5, tonicity-responsive |
C00002568
|
| 4772 | NFATC1, NF-ATC, NFAT2, NFATc | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
C00002568
|
| 51129 | ANGPTL4, ANGPTL2, ARP4, FIAF, HARP, HFARP, NL2, PGAR, UNQ171, pp1158 | angiopoietin-like 4 |
C00002522
|
| 4879 | NPPB, BNP | natriuretic peptide B |
C00002568
|
| 4521 | NUDT1, MTH1 | nudix (nucleoside diphosphate linked moiety X)-type motif 1 (EC:3.6.1.55 3.6.1.56) |
C00002568
|
| 4976 | OPA1, MGM1, NPG, NTG, largeG | optic atrophy 1 (autosomal dominant) (EC:3.6.5.5) |
C00002568
|
| 126014 | OSCAR, PIGR3, PIgR-3 | osteoclast associated, immunoglobulin-like receptor |
C00002568
|
| 5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00002568
|
| 11315 | PARK7, DJ-1, DJ1 | parkinson protein 7 |
C00002568
|
| 5162 | PDHB, PDHBD, PDHE1-B, PHE1B | pyruvate dehydrogenase (lipoamide) beta (EC:1.2.4.1) |
C00002568
|
| 65018 | PINK1, BRPK, PARK6 | PTEN induced putative kinase 1 (EC:2.7.11.1) |
C00002568
|
| 5422 | POLA1, POLA, p180 | polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7) |
C00002568
|
| 5427 | POLE2, DPE2 | polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7) |
C00002568
|
| 5481 | PPID, CYP-40, CYPD | peptidylprolyl isomerase D (EC:5.2.1.8) |
C00002568
|
| 5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00002568
|
| 8842 | PROM1, AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4 | prominin 1 |
C00002568
|
| 5810 | RAD1, HRAD1, REC1 | RAD1 homolog (S. pombe) (EC:3.1.11.2) |
C00002568
|
| 5884 | RAD17, CCYC, HRAD17, R24L, RAD17SP, RAD24 | RAD17 homolog (S. pombe) |
C00002568
|
| 56852 | RAD18, RNF73 | RAD18 homolog (S. cerevisiae) |
C00002568
|
| 10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00002568
|
| 5888 | RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA | RAD51 recombinase |
C00002568
|
| 10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00002568
|
| 25788 | RAD54B, RDH54 | RAD54 homolog B (S. cerevisiae) |
C00002568
|
| 5883 | RAD9A, RAD9 | RAD9 homolog A (S. pombe) (EC:3.1.11.2) |
C00002568
|
| 5984 | RFC4, A1, RFC37 | replication factor C (activator 1) 4, 37kDa |
C00002568
|
| 5985 | RFC5, RFC36 | replication factor C (activator 1) 5, 36.5kDa |
C00002568
|
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00002568
|
| 6539 | SLC6A12, BGT-1, BGT1, GAT2 | solute carrier family 6 (neurotransmitter transporter), member 12 |
C00002568
|
| 6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00002568
|
| 6606 | SMN1, BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3, SMA4, SMA@, SMN, SMNT, T-BCD541, TDRD16A | survival of motor neuron 1, telomeric |
C00002568
|
| 6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002568
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002568
|
| 8878 | SQSTM1, A170, OSIL, PDB3, ZIP3, p60, p62, p62B | sequestosome 1 |
C00002568
|
| 133 | ADM, AM | adrenomedullin |
C00002522
|
| 6742 | SSBP1, Mt-SSB, SOSS-B1, SSBP, mtSSB | single-stranded DNA binding protein 1, mitochondrial |
C00002568
|
| 6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00002568
|
| 7084 | TK2, MTDPS2, MTTK | thymidine kinase 2, mitochondrial (EC:2.7.1.21) |
C00002568
|
| 4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00002568
|
| 8600 | TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf | tumor necrosis factor (ligand) superfamily, member 11 |
C00002568
|
| 25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00002568
|
| 7334 | UBE2N, UBC13, UbcH-ben, UbcH13 | ubiquitin-conjugating enzyme E2N (EC:6.3.2.19) |
C00002568
|
| 7381 | UQCRB, MC3DN3, QCR7, QP-C, QPC, UQBC, UQBP, UQCR6, UQPC | ubiquinol-cytochrome c reductase binding protein (EC:1.10.2.2) |
C00002568
|
| 7384 | UQCRC1, D3S3191, QCR1, UQCR1 | ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2) |
C00002568
|
| 7416 | VDAC1, PORIN, VDAC-1 | voltage-dependent anion channel 1 |
C00002568
|
| 7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00002568
|
| 7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00002568
|
| 7529 | YWHAB, GW128, HS1, KCIP-1, YWHAA | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
C00002568
|
| 7532 | YWHAG, 14-3-3GAMMA | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
C00002568
|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001232
|
| 9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00001232
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000960
|
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00001232
|
| 335 | APOA1 | apolipoprotein A-I |
C00001232
|
| 338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001232
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001232
|
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00001232
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001232
|
| 3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001232
|
| 5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001232
|
| 778733 |
C00001232
|
||
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001232
|
| 100136658 |
C00001232
|
||
| 5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00001232
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00001232
|
| 6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00001232
|
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00001232
|
| 6514 | SLC2A2, GLUT2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
C00001232
|
| 177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000674
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000674
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000674
|
| 890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00000674
|
| 891 | CCNB1, CCNB | cyclin B1 |
C00000674
|
| 958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00000674
|
| 972 | CD74, DHLAG, HLADG, II, Ia-GAMMA | CD74 molecule, major histocompatibility complex, class II invariant chain |
C00000674
|
| 983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000674
|
| 4015 | LOX | lysyl oxidase (EC:1.4.3.13) |
C00002522
|
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000674
|
| 1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00000674
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00000674
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000674
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000674
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000674
|
| 1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00000674
|
| 1950 | EGF, HOMG4, URG | epidermal growth factor |
C00000674
|
| 1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00000674
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000674
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000674
|
| 2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00000674
|
| 2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00000674
|
| 4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00000674
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000674
|
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00000674
|
| 3726 | JUNB, AP-1 | jun B proto-oncogene |
C00000674
|
| 3727 | JUND, AP-1 | jun D proto-oncogene |
C00000674
|
| 5602 | MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK | mitogen-activated protein kinase 10 (EC:2.7.11.24) |
C00000674
|
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00000674
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00000674
|
| 4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00000674
|
| 9572 | NR1D1, EAR1, THRA1, THRAL, ear-1, hRev | nuclear receptor subfamily 1, group D, member 1 |
C00000674
|
| 5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00000674
|
| 8000 | PSCA, PRO232 | prostate stem cell antigen |
C00000674
|
| 5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00000674
|
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000674
|
| 2810 | SFN, YWHAS | stratifin |
C00000674
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000674
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000674
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000674
|
| 9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00000674
|
| 8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000674
|
| 7161 | TP73, P73 | tumor protein p73 |
C00000674
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000674
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00000674
|
| 10451 | VAV3 | vav 3 guanine nucleotide exchange factor |
C00000674
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000674
|
| 8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00000674
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #208900 | Ataxia-telangiectasia; at |
Q13315
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
| #613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
| #114500 | Colorectal cancer; crc |
P18054
P84022 Q14191 |
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #162800 | Cyclic neutropenia |
P08246
|
| #613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
P18054 |
| #615363 | Estrogen resistance; estrr |
P03372
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #230200 | Galactokinase deficiency |
P51570
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
| #232300 | Glycogen storage disease ii |
P10253
|
| #139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #535000 | Leber optic atrophy |
P03905
|
| #500001 | Leber optic atrophy and dystonia |
P03905
|
| #601626 | Leukemia, acute myeloid; aml |
P36888
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes; melas |
P03905
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
P38398 |
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #604229 | Peters anomaly |
Q16678
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
O14763
P04637 |
| %612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
| #601367 | Stroke, ischemic |
P00734
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #187950 | Thrombocythemia 1; thcyt1 |
P40225
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #277700 | Werner syndrome; wrn |
Q14191
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278300 | Xanthinuria, type i |
P47989
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) Q15046 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00068 | Leber optic atrophy |
P03905
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P28907 (marker) Q13315 (related) |
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00023 | Testicular cancer |
P10696
(marker)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00070 | Galactosemia |
P51570
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
| H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
| H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D003072 | Cognition Disorders |
C00019308
C00001232 |
| D020955 | Striatonigral Degeneration |
C00002568
|
| D013118 | Spinal Cord Diseases |
C00019308
|
| D001943 | Breast Neoplasms |
C00002522
|
| D006528 | Carcinoma, Hepatocellular |
C00002522
|
| D008175 | Lung Neoplasms |
C00002522
|
| D008207 | Lymphatic Metastasis |
C00002522
|
| D009361 | Neoplasm Invasiveness |
C00002522
|
| D009362 | Neoplasm Metastasis |
C00002522
|
| D009369 | Neoplasms |
C00002522
|
| D009374 | Neoplasms, Experimental |
C00002522
|
| D011471 | Prostatic Neoplasms |
C00002522
|
| D012878 | Skin Neoplasms |
C00002522
|
| D001766 | Blindness |
C00002568
|
| D001862 | Bone Resorption |
C00002568
|
| D001930 | Brain Injuries |
C00002568
|
| D002375 | Catalepsy |
C00002568
|
| D002561 | Cerebrovascular Disorders |
C00002568
|
| D003643 | Death |
C00002568
|
| D004195 | Disease Models, Animal |
C00002568
|
| D056486 | Drug-Induced Liver Injury |
C00002568
|
| D020820 | Dyskinesias |
C00002568
|
| D004421 | Dystonia |
C00002568
|
| D005767 | Gastrointestinal Diseases |
C00002568
|
| D005911 | Gliosis |
C00002568
|
| D006470 | Hemorrhage |
C00002568
|
| D006930 | Hyperalgesia |
C00002568
|
| D018476 | Hypokinesia |
C00002568
|
| D007249 | Inflammation |
C00002568
|
| D020961 | Lewy Body Disease |
C00002568
|
| D028361 | Mitochondrial Diseases |
C00002568
|
| D016472 | Motor Neuron Disease |
C00002568
|
| D009069 | Movement Disorders |
C00002568
|
| D009127 | Muscle Rigidity |
C00002568
|
| D009336 | Necrosis |
C00002568
|
| D009410 | Nerve Degeneration |
C00002568
|
| D009437 | Neuralgia |
C00002568
|
| D019636 | Neurodegenerative Diseases |
C00002568
|
| D020879 | Neuromuscular Manifestations |
C00002568
|
| D020258 | Neurotoxicity Syndromes |
C00002568
|
| D029242 | Optic Atrophy, Hereditary, Leber |
C00002568
|
| D009901 | Optic Nerve Diseases |
C00002568
|
| D010190 | Pancreatic Neoplasms |
C00002568
|
| D010300 | Parkinson Disease |
C00002568
|
| D010302 | Parkinson Disease, Secondary |
C00002568
|
| D020734 | Parkinsonian Disorders |
C00002568
|
| D015427 | Reperfusion Injury |
C00002568
|
| D012162 | Retinal Degeneration |
C00002568
|
| D012798 | Sialorrhea |
C00002568
|
| D012818 | Signs and Symptoms, Respiratory |
C00002568
|
| D012893 | Sleep Disorders |
C00002568
|
| D002493 | Central Nervous System Diseases |
C00019308
|
| D024801 | Tauopathies |
C00002568
|
| D014786 | Vision Disorders |
C00002568
|
| D015431 | Weight Loss |
C00002568
|
| D055371 | Acute Lung Injury |
C00001232
|
| D000860 | Anoxia |
C00001232
|
| D005234 | Fatty Liver |
C00001232
|
| D006520 | Hepatitis, Animal |
C00001232
|
| D007333 | Insulin Resistance |
C00001232
|
| D055370 | Lung Injury |
C00001232
|
| D011654 | Pulmonary Edema |
C00001232
|
| D012128 | Respiratory Distress Syndrome, Adult |
C00001232
|
| D009202 | Cardiomyopathies |
C00000674
|
| D002386 | Cataract |
C00000674
|
| D005483 | Flushing |
C00000674
|
| D006529 | Hepatomegaly |
C00000674
|
| D008103 | Liver Cirrhosis |
C00000674
|
| D010051 | Ovarian Neoplasms |
C00000674
|